CLINICAL_TRIALS
trial_result
· 2019-09-27
Clinical Trial Update: Approaches To Therapy Escalation In T2D [Phase 4]
Summary
A Phase 4 clinical trial investigating therapy escalation approaches in Type 2 Diabetes has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: LMC Diabetes & Endocrinology Ltd. | Conditions: Type2 Diabetes | Phase 4 | Status: WITHDRAWN